Logo image of RNWK

REALNETWORKS INC (RNWK) Stock Fundamental Analysis

NASDAQ:RNWK - Nasdaq - US75605L7082 - Common Stock - Currency: USD

0.73  +0 (+0.03%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RNWK. RNWK was compared to 284 industry peers in the Software industry. The financial health of RNWK is average, but there are quite some concerns on its profitability. RNWK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RNWK had negative earnings in the past year.
RNWK had a negative operating cash flow in the past year.
RNWK Yearly Net Income VS EBIT VS OCF VS FCFRNWK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 -20M -40M -60M -80M

1.2 Ratios

RNWK has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RNWK Yearly ROA, ROE, ROICRNWK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -20 -40 -60

1.3 Margins

RNWK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RNWK Yearly Profit, Operating, Gross MarginsRNWK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

RNWK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RNWK has more shares outstanding
RNWK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RNWK Yearly Shares OutstandingRNWK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
RNWK Yearly Total Debt VS Total AssetsRNWK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M

2.2 Solvency

RNWK has an Altman-Z score of -16.59. This is a bad value and indicates that RNWK is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RNWK (-16.59) is worse than 94.33% of its industry peers.
RNWK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -16.59
ROIC/WACCN/A
WACC10.48%
RNWK Yearly LT Debt VS Equity VS FCFRNWK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 1.39 indicates that RNWK should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.39, RNWK is doing worse than 61.67% of the companies in the same industry.
RNWK has a Quick Ratio of 1.39. This is a normal value and indicates that RNWK is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.39, RNWK is not doing good in the industry: 60.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.39
RNWK Yearly Current Assets VS Current LiabilitesRNWK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for RNWK have decreased strongly by -10.81% in the last year.
The Revenue for RNWK has decreased by -19.47% in the past year. This is quite bad
RNWK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.52% yearly.
EPS 1Y (TTM)-10.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)-19.47%
Revenue growth 3Y-5.75%
Revenue growth 5Y-6.52%
Sales Q2Q%-18.31%

3.2 Future

The Earnings Per Share is expected to grow by 15.96% on average over the next years. This is quite good.
Based on estimates for the next years, RNWK will show a decrease in Revenue. The Revenue will decrease by -3.12% on average per year.
EPS Next Y-46.57%
EPS Next 2Y-48.02%
EPS Next 3Y23.3%
EPS Next 5Y15.96%
Revenue Next Year-14.21%
Revenue Next 2Y-3.01%
Revenue Next 3Y-3.4%
Revenue Next 5Y-3.12%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RNWK Yearly Revenue VS EstimatesRNWK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
RNWK Yearly EPS VS EstimatesRNWK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RNWK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RNWK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RNWK Price Earnings VS Forward Price EarningsRNWK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RNWK Per share dataRNWK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

RNWK's earnings are expected to grow with 23.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-48.02%
EPS Next 3Y23.3%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RNWK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REALNETWORKS INC

NASDAQ:RNWK (12/21/2022, 8:00:02 PM)

0.73

+0 (+0.03%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-28 2022-07-28/amc
Earnings (Next)02-07 2023-02-07
Inst Owners0.01%
Inst Owner Change0%
Ins Owners15.7%
Ins Owner Change0%
Market Cap34.82M
Analysts82.86
Price Target3.06 (319.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.73%
Min EPS beat(2)-5.58%
Max EPS beat(2)17.04%
EPS beat(4)3
Avg EPS beat(4)20.19%
Min EPS beat(4)-5.58%
Max EPS beat(4)59.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.26%
Min Revenue beat(2)-11.02%
Max Revenue beat(2)-1.5%
Revenue beat(4)1
Avg Revenue beat(4)-3.49%
Min Revenue beat(4)-11.02%
Max Revenue beat(4)6.69%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-75.88%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.69
P/FCF N/A
P/OCF N/A
P/B 1.23
P/tB 2.83
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)-1.34
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS1.05
BVpS0.6
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.47%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.39
Altman-Z -16.59
F-Score2
WACC10.48%
ROIC/WACCN/A
Cap/Depr(3y)42.45%
Cap/Depr(5y)37.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y-46.57%
EPS Next 2Y-48.02%
EPS Next 3Y23.3%
EPS Next 5Y15.96%
Revenue 1Y (TTM)-19.47%
Revenue growth 3Y-5.75%
Revenue growth 5Y-6.52%
Sales Q2Q%-18.31%
Revenue Next Year-14.21%
Revenue Next 2Y-3.01%
Revenue Next 3Y-3.4%
Revenue Next 5Y-3.12%
EBIT growth 1Y-25.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.6%
EBIT Next 3Y26.19%
EBIT Next 5Y19%
FCF growth 1Y-4.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.1%
OCF growth 3YN/A
OCF growth 5YN/A